__

SSHO, South Shore Resources Inc., SSHO.PK

Global demand for oil exceeds 80 million barrels per day.

Companies like SSHO could make a difference. SSHO is in the right place at the right time.

In April 2010, the Transportation Department and Environmental Protection Agency reached a peaceful end to a bitter legal battle with the automobile industry on how to deal with the dangerous gas emitted from automobiles, wherein a series of new fuel efficiency standards were adopted to regulate tailpipe emissions.

The US Environmental Protection Agency (EPA) and the National Highway Traffic Safety Administration (NHTSA) are taking the next steps to reduce greenhouse gas (GHG) emissions and improve fuel efficiency from on-road vehicles and engines. These next steps include developing first-ever GHG regulations for heavy-duty engines and vehicles, as well as further light-duty vehicle GHG regulations. These steps were outlined by President Obama in a memorandum on May 21, 2010.

Recently, Canada introduced the country’s first mandatory emission rules for cars and trucks, harmonizing the standards with the United States.

Canada’s new measures will force each automaker to achieve a combined average fuel economy for all the models it sells of 35.5 miles per gallon by 2016. That is equivalent in Canada to about 6.6 litres of gasoline usage for every 100 kilometres driven.

SSHO is a company engaged in the development of products which are committed to the reduction of harmful greenhouse gases and fuel savings with the use of Hydrogen Generating Modules and related accessories to the transportation and automotive industries which are either in development and/or the commercialization stages.

SSHO reported that it has conducted independent third party evaluation, testing and verification of the HyProStar Series of Hydrogen Generating Modules.

The objective of the evaluation and test was to evaluate, test and verify the impact that SSHO’s HyProStar Series of Hydrogen Generating Modules has on fuel economy and fuel efficiency.

DaSilva Racing of Pickering, Ontario was utilized for third party evaluation, testing and verification purposes.

A 2002 Volkswagen Cabrio was run for 15 minutes each at 80 KPH / 50 MPH on a stationary Dyno Jet for both Without the Unit and With the HyProStar Unit installed. The MPG Testing was conducted and recorded using a ScanGuageII by Linear Logic LLC for both Without the Unit and With the SSHO’s HyProStar Unit installed.

Test Results Are Summarized Below:

2002 Volkswagen Cabrio: Mileage Test

Without Unit: 47 MPG
With Unit: 55 MPG

There was a 17.02% increase in MPG.
There was a 14.55% fuel savings.

The results of the evaluation and testing indicated and verified by Mr. Joe DaSilva (of DaSilva Racing) are that SSHO’s HyProStar Series of Hydrogen Generating Modules have increased in fuel economy and fuel efficiency.

SSHO believes that its HyProStar Series of Hydrogen Generating Modules are an obvious aftermarket alternative to Rising Fuel Prices and Harmful Greenhouse Gases.

SSHO is now poised to commercialize its HyProStar Hydrogen Generator Hybrid Conversion Kit and bring it to the global market. With over 750 million automobiles currently using combustible engines world wide and the increased pressure to reduce greenhouse gases, SSHO is confident that now is the time to aggressively enter this market.

More about SSHO at www.southshoreresourcesinc.com

**************************************************************

APA, Apache Corporation

APA is an oil and gas exploration and production company with operations in the United States, Canada, Egypt, the United Kingdom North Sea, Australia and Argentina.

** APA reported the pricing of offerings of common stock and depositary shares raising approximately $3.1 billion with underwriters’ options that may bring in up to an additional $469 million.

APA has priced its offering of 23 million shares of common stock at a public offering price of $88.00 per share, or approximately $2.0 billion. The size of the common stock offering was increased from the previously announced 21 million shares.

APA also sold 22 million depositary shares for $1.1 billion. Each depositary share represents a 1/20th interest in a share of Apache’s 6.00% Mandatory Convertible Preferred Stock, Series D, with an initial liquidation preference of $1,000 per share (equivalent to $50 liquidation preference per depositary share).

APA has granted the underwriters a 30-day option to purchase up to 3.45 million additional shares of its common stock and up to 3.3 million additional depositary shares.

More about APA at www.apachecorp.com

**************************************************************

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer ) . Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received fifty thousand dollars from a third party (Fassi SA) for thirty days of advertisement services for South Shore Resources Inc. (SSHO.PK).

__

Power 3 Medical Products Inc. (OTC BB: PWRM) recently has unexpectedly discovered new and unprecedented findings regarding clinically important differences in the response of the NuroPro protein biomarkers in the blood of untreated Alzheimer’s disease patients compared to patients treated with the widely used anti-dementia drugs Aricept (Donepezil HCl, Pfizer – NYSE: PFE), Exelon (Rivastigmine, Novartis – NYSE: NVS), and Namenda (Memantine HCl, Forest Laboratories – NYSE: FRX). These results relate to the genetically distinct groups of Alzheimer’s disease patients, i.e., those individuals who possess the Alzheimer’s high-risk gene for Apolipoprotein E4 and those who do not possess the gene. PWRM’s NuroPro was originally indicated for diagnostics to determine whether or not a patient had Alzheimer’s disease. With these results, PWRM’s NuroPro now extends into the pharmaceutical arena due to its ability to predict and monitor the response to drug treatment, including the underlying disease process and the insidious progression of irreversible neurological damage, even in the face of temporary improvements in cognition and other symptoms

DG FastChannel®, Inc. (NASDAQ: DGIT) reported that it will report its second quarter financial results before the market opens on Wednesday, August 4, 2010. The Company will host a conference call and webcast at 10:00 a.m. ET that morning to review the results.

Highwoods Properties (NYSE: HIW) Board of Directors declared a cash dividend of $0.425 per share of common stock for the quarter ended June 30, 2010, which equates to an annual dividend of $1.70 per share and is payable on September 8, 2010 to shareholders of record as of August 16, 2010.

RSC Holdings Inc. (NYSE: RRR), one of the largest equipment rental providers in North America, reported financial results for the quarter ended June 30, 2010. Total revenue was $301 million and rental revenue was $260 million, compared with $327 million and $271 million, respectively, for the same period last year. The company reported a second quarter net loss of $22 million, or $0.21 per diluted share, compared with a net loss of $11 million, or $0.11 per diluted share, for the second quarter 2009.

Hypercom Corporation (NYSE: HYC) has scheduled its conference call to discuss second quarter 2010 results for Wednesday, August 4, at 4:30 p.m. ET. The call will be simultaneously webcast.

**************************************************************

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer ) . Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. has previously received five hundred thousand shares compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Recently, Crown Equity Holdings, Inc has received an additional amount of 2,000,000 shares of free trading stock for 60 days media advertisement, web design and maintenance for Power 3 Medical Products Inc. (PWRM.OB).

__

TaxMasters, Inc. (OTCBB: TAXS) filed a Current Report on Form 8-K on Wednesday, July 7, 2010 to announce that Patrick Cox, its founder, CEO and majority shareholder, voluntarily entered into a Financial Reorganization Agreement in which Mr. Cox deposited 200 million shares of his TaxMasters common stock with TaxMasters’ transfer agent, Olde Monmouth Stock Transfer Co., Inc. These shares will be held in escrow by Olde Monmouth for a five year period ending June 30, 2015. During that time, Mr. Cox has waived his right to vote the escrowed shares and he has also waived his right to receive any dividends or other distributions by TaxMasters with respect to the escrowed shares. As a result of Mr. Cox’s voluntary escrow of shares, there are now 139,676,105 shares of common stock that can be voted or can receive dividends or other distributions. The 139,676,105 shares will also be the number of shares used to calculate earnings per share for TaxMasters financial statements. After each fiscal year during the five years that Mr. Cox’s shares are being held in escrow, Mr. Cox may claw back a portion of the escrowed shares based on a formula linked to the financial performance of TaxMasters. Any shares Mr. Cox does not claw back prior to June 30, 2015 will be turned over to the Company for cancellation. As a result of the Financial Reorganization Agreement, shareholders will have an increased voting power in their stock. For example, a shareholder owning 1,000,000 shares of TaxMasters common stock will have an increase of the voting power of such stock from 0.3% of the voting power to 0.7% of the voting power.

Comfort Systems USA, Inc. (NYSE: FIX), a leading provider of commercial, industrial and institutional heating, ventilation and air conditioning (“HVAC”) services, reported that it has scheduled its quarterly conference call for Tuesday, August 3, 2010 at 10:00 a.m. Central Time to discuss second quarter 2010 financial results. The results will be released after the market closes on Monday, August 2, 2010.

Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp. (NASDAQ: AMSG), reported financial results for the second quarter ended June 30, 2010. Revenues were $179,895,000 for the quarter, an increase of 7% from $168,844,000 for the second quarter of 2009. Net earnings from continuing operations attributable to AmSurg common shareholders for the second quarter of 2010 were $13,133,000, or $0.43 per diluted share, compared with $13,798,000, or $0.45 per diluted share, for the second quarter last year. The results for the second quarter of 2010 included an incremental negative impact of $0.01 per diluted share from the revision of the Medicare payment system for ASCs and $0.02 per diluted share from the higher interest costs related to the refinancing of the Company’s credit facility in May 2010.

Keynote Systems (NASDAQ: KEYN), the global leader in solutions for continuously improving the Internet and mobile experience, and OPNET Technologies, Inc. (NASDAQ: OPNT), a leading provider of solutions for managing application and network performance, today announced a strategic alliance that focuses on maximizing the performance and availability of web applications for corporate enterprises and government agencies worldwide. Key initiatives of the alliance include technical collaboration and coordinated marketing and sales efforts that emphasize each company’s best-in-class technologies. The OPNET/Keynote offering enables proactive, 24×7 visibility into the performance of critical applications from multiple geographic locations using a combination of real user traffic and synthetic transaction monitoring.

**************************************************************

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer ) . Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received twenty four thousand dollars from Tax Masters Inc.(TAXS.OB) for 30 days of advertisement services. Crown Equity Holdings, Inc. (CRWE.OB) has received four thousand dollars from a third party (Marshall Curtis) for 30 days of advertisement for services for Tax Masters Inc.(TAXS.OB) which has expired. Crown Equity Holdings, Inc. has received an additional four thousand dollars from the same third party (Marshall Curtis) for an additional 30 days of advertisement services

__

ETFC, E*TRADE Financial Corporation

ETFC, through its subsidiaries, provides online brokerage and related products and services primarily to individual retail investors under the E*TRADE Financial brand name worldwide.

** ETFC posted its first quarterly profit in three years **

ETFC reported results for its second quarter ended June 30, 2010,

- Net income of $35 million, or $0.12 per share, compared with a net loss of $48 million, or $0.25 loss per share, in the prior quarter and a net loss of $143 million, or $2.16 loss per share, in the second quarter of 2009. ETFC reported total net revenue of $534 million for the second quarter, compared with $537 million in the prior quarter and $621 million in the year ago period.

More about ETFC at www.etrade.com

**************************************************************

EVCA, EVCARCO Inc., EVCA.OB

EVCA is the first automotive retail group dedicated to deploying a coast-to-coast network of eco-friendly dealerships and vehicles.

EVCA is bringing to market the most advanced clean technologies available in plug-in electric and alternative fuel vehicles.

Green technology is not only the path to the future, it is the future.

The highway may soon see a whole generation of cars that run on alternative energy, it is not only good for the environment, it is important for the survival of the human race.

Fossil fuels have wrought havoc on the environment, one look at the Gulf Coast should be enough to run in fear of the next off shore development, yet that is where all countries surrounded by oceans are heading. Fossil fuels are responsible for contaminating the air we breathe making clears air a thing of the past but working together we may also make clean air a thing of the future.

EVCA understands what fossil fuels have done to our ecology, and they plan to make a difference by setting up the first dealerships catering exclusively to alternative fuel vehicles, what a great idea and this is the grown floor opportunity for anyone with an interest in our environment.

EVCA has developed a dealer network allowing growth into most US States by 2012.

The environment is a global problem. That’s why EVCA is looking at areas that need its products the most, when EVCA looks at Mexico City, Mexico with a 28 million population or Lima, Peru, EVCA sees huge requirement for real World Solutions, which is why EVCA is now poised to enter the market.

** EVCA has approved the expansion of its operations into South America. EVCA has appointed Bogota, Colombia as its base of operations for the Texas Corporation.

EVCA plans to introduce the following elements to South America:

1. Government alternative energy advisory

2. Public and commercial electric vehicles

3. Mass transit alternative fuel units

4. All electric taxi and high use units

5. Other viable electric vehicle transportation

EVCA has key executives creating alliances with South American governments for long range programs aimed at fossil fuel reduction and adoption of electric vehicles.

Everyone should have an interest in watching EVCA to see where they can go and what their stock may be worth. If their plans for the year ahead come to fruition, their stock could change its trading levels in no time!

More about EVCA at www.evcarco.com

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer ) . Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received fifteen thousand dollars in cash and thirty-five thousand EVCARCO, Inc. (EVCA.OB) restricted shares for 30 days of advertising services.

__

PROT, Proteonomix, Inc., PROT.OB

PROT is proving that good things grow in Mountainside, New Jersey, not just in the summer but all year long.

PROT, which focuses on stem cell therapies for diabetes and cardiac injury, is planning to lead the research community into the future with the introduction of a new platform for growing contaminant-free human stem cells, which will serve as a catalyst for bringing feasible treatments to market.

Working with top scientists and institutions around the world, PROT is also working on dramatically increasing the donor-recipient match rate by establishing a cord blood bank that uses proprietary technology. Umbilical cord blood stem cells are already recognized as a viable therapy for more than 80 diseases, a number that continues to grow.

In tandem with this,PROT will also be launching a genetic diversity program to increase the currently under-represented minority groups in the pool of available cord blood stem cell units.

Many of the currently incurable diseases associated with aging are caused by the degeneration of specific cell types in the body. These diseases include but are not limited to cancer, heart disease, diabetes, and autoimmune conditions. Stem cell therapy provides much promise for the treatment of diseases previously regarded as incurable.

PROT’s mission is to achieve a leadership position in life enhancement regenerative stem cell therapies, services, and products through a combination of first to market technologies, and innovative clinical trial strategies.

1) Through PROT’s operating subsidiary, National Stem Cell, PROT has developed a catalog of intellectual properties and patent applications.

These technologies are designed to work together in a synergistic fashion. PROT’s initial focus in stem cell therapeutics is to achieve a leadership position in:

* the development of identification biomarkers (a biomarker is a substance used as an indicator of a biological state which refers to the complete range of genes found in biological structure and processes of the living body, including the nervous system, the endocrine system, and our senses of sight, hearing, taste, smell, and touch. It is a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention) cell derivatives, and cellular proteins.

* the development of stem cell therapies for disease and injury; and

* the performance of reproductive cell/tissue laboratory services.

PROT needs to test these technologies and therapies before commercialization.

PROT has identified stem cells in the human pancreas and have applied for patents for cell surface markers (the molecules present on the surface of each cell which define the cell on what receptors are present - a technique often used to associate cells with certain immune functions) for these pancreatic stem cells as well as methods for their isolation.

Based on the fact that these cells are autologous (from same person) rather than from a non-related donor, PROT anticipates that the cells that the company is able to isolate will substantially reduce rejection when transplanted into the liver of the same diabetic patient. PROT is performing further research in this area with the University of Miami.

2) Through National Stem Cell, PROT has developed a patent-pending container device for cryopreservation of stem cells (the process where cells are preserved by cooling to low sub-zero temperatures) that the company believes will provide significant improvements in viable cell recovery and contaminant protection, both in freezing and thawing stem cells, than is found with cryostorage containers currently in use.

3) Multiple cosmetic products have been developed. The products are based on PROT’s patents describing its Secreted Matrix TM technology. These products are in production and their launch is scheduled for 2010.

4) Laboratory services are provided by PROT’s wholly owned, accredited and operating reproductive cell/tissue banking service (sperm, ova, ovarian tissue, testicular tissue and embryos).

It is anticipated that PROT’s laboratory services will provide advanced technologies and procedures for the collection, laboratory testing, bio-genetic typing, processing and cryogenic storage of stem cells from both umbilical cord and peripheral blood. Umbilical cord blood stem cells and reproductive cells are processed and banked for both allogeneic (transfer from one person to another) and autologous (derived from and used by the same individual) therapeutic transplantation for a variety of medical disorders, including leukemia and lymphoma with stem cells and infertility with sperm cells.

PROT has developed and implemented a unique, effective and comprehensive strategy for the marketing of its services and products on a national and international scale for applications in stem cell therapeutics together with cell-tissue laboratory services.

** PROT is interested in identifying strategic partnerships and opportunities for products and technology.

PROT can provide attractive compensation for any new leads that result in new partnerships and business opportunities (Source: CLICK HERE).

More about PROT at www.proteonomix.com

**************************************************************

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer ) . Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading share from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB)